(Q73906894)

English

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators

scientific article published on 01 June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Hans-Christoph Diener

5

object named as

H C Diener

1 reference

Europe PubMed Central

7 November 2019

author name string

K R Lees

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Asplund

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Carolei

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S M Davis

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Kaste

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J M Orgogozo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Whitehead

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

355

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1949-1954

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

9219

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II studies of the glycine antagonist GV150526 in acute stroke : the North American experience. The North American Glycine Antagonist in Neuroprotection (GAIN) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug development for stroke: importance of protecting cerebral white matter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the Barthel index and modified Rankin scale in acute stroke trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Which targets are relevant for therapy of acute ischemic stroke?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping the ischaemic penumbra with PET: implications for acute stroke treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902326-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02326-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10859040%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73906894&oldid=1671419693"